Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Chimeric antigen receptors comprising BCMA-specific fibronectin type III domains and uses thereof

Chimeric antigen receptors comprising BCMA-specific fibronectin type III domains and uses thereof

US Patent 11096998 · Granted Aug 24, 2021

Estimated economic value: $283,341,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antigen binding regions against fibronectin type III domains and methods of usin2025
Antigen binding regions against fibronectin type III domains and methods of usin2025
Antigen binding regions against fibronectin type III domains and methods of usin2025
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof2025
Anti-idiotypic antibodies against anti-KLK2 antibodies2024
Proteins comprising kallikrein related peptidase 2 antigen binding domains and t2024
GPRC5D chimeric antigen receptors and cells expressing the same2024
Anti-human kallikrein-2 (hK2) chimeric antigen receptor (CAR) and methods of use2024
Anti-idiotypic antibodies against anti-GPRC5D antibodies2024
B7H4-targeted antibody-drug conjugates and methods of use thereof2024
Chimeric antigen receptor system with adaptable receptor specificity2024
PSMA binding agents and uses thereof2023